Japan’s Drug Maker M&A Activity Expected To Continue Record Pace

The already recording-setting mergers and acquisitions by Japanese companies, including drug makers, is expected to continue as others seek to add to foreign holdings. The companies of the second-largest economy in the world are expected to take advantage of the credit crisis around the world, according to industry insiders. Together, Japanese firms so far this year have made acquisitions worth a combined $47.1 billion, well over the previous record covering all of 2006. Besides Japanese pharmas, makers of auto parts and financial firms are expected to lead the M&A activity. (Click here for more